Evidence map›Paper›PMID 28446445›Full record

ReviewClinical microbiology reviews2017

Susceptibility Testing of Medically Important Parasites.

Abebe Genetu Bayih, Anjan Debnath, Edward Mitre, Christopher D Huston, Benoît Laleu, Didier Leroy, Benjamin Blasco, Brice Campo, Timothy N C Wells, Paul A Willis and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical microbiology reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Abebe Genetu BayihDepartment of Pathology, Medicine, and Microbiology, University of Calgary, Calgary, AB, Canada.
Anjan DebnathCenter for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, La Jolla, California, USA.
Edward MitreDepartment of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Christopher D HustonDepartment of Medicine, University of Vermont, Burlington, Vermont, USA.
Benoît LaleuMedicines for Malaria Venture, Geneva, Switzerland.
Didier LeroyMedicines for Malaria Venture, Geneva, Switzerland.
Benjamin BlascoMedicines for Malaria Venture, Geneva, Switzerland.
Brice CampoMedicines for Malaria Venture, Geneva, Switzerland.
Timothy N C WellsMedicines for Malaria Venture, Geneva, Switzerland.
Paul A WillisMedicines for Malaria Venture, Geneva, Switzerland.
Peter SjöDepartment of Medicinal Chemistry, RIA, Astra Zeneca R&D, Gothenburg, Sweden.
Wesley C Van VoorhisDivision of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA.
Dylan R PillaiDepartment of Pathology, Medicine, and Microbiology, University of Calgary, Calgary, AB, Canada drpillai@ucalgary.ca.

Funding

UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Novel approaches to develop a treatment for cryptosporidiosisR21AI101381 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUSTON, CHRISTOPHER D · 2013 to 2014
$419k
NCATS NIH HHS KL2 TR001444NIAID NIH HHS R21 AI101381NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

In the last 2 decades, renewed attention to neglected tropical diseases (NTDs) has spurred the development of antiparasitic agents, especially in light of emerging drug resistance. The need for new drugs has required

Indexed as

AnimalsAntiparasitic AgentsDrug DiscoveryHumansNeglected DiseasesParasitesAntiparasitic Agentsparasitesresistancesusceptibility tests

Identifiers

PMID28446445
PMCPMC5475223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.